EC Number   |
Protein Variants |
Reference |
|---|
   3.4.22.B6 | D127A |
mutation completely inhibits secretion |
752893 |
| 3.4.22.B6 | G234E |
mutation increases activity towards benzyloxycarbonyl-Arg-ARg-7-amido-4-methylcoumarin, 8fold over the wild-type recombinant enzyme |
647655 |
| 3.4.22.B6 | G336E |
mutation is sufficient to confer AtCathB2 with the capacity to tolerate arginine in its specificity-determining S2 subsite, i.e. to introduce isoform CathB3-like specificity |
752893 |
| 3.4.22.B6 | H207A |
mutation of the carboxydipeptidase determinant, also affects the activity of CathB2 towards non-exopeptidase substrates |
752893 |
| 3.4.22.B6 | N216D |
predicted glycosylation site |
710348 |
| 3.4.22.B6 | N97Q/N207Q |
(putative) glycosylation sites |
708228 |
| 3.4.22.B6 | N97Q/N207Q/N100Q |
(putative) glycosylation sites |
708228 |
| 3.4.22.B6 | N97Q/N207Q/N111Q |
(putative) glycosylation sites |
708228 |
| 3.4.22.B6 | N97Q/N207Q/N111Q/N236Q |
(putative) glycosylation sites |
708228 |
| 3.4.22.B6 | N97Q/N207Q/N236Q |
(putative) glycosylation sites |
708228 |
